Substrate
finance

U.S. Stocks Trade Mixed as Dow Declines Over 150 Points

U.S. stock indexes showed mixed performance during midday trading on Friday, with the Dow Jones Industrial Average down more than 150 points. The NASDAQ and S&P 500 posted gains, driven by strength in information technology shares. Procter & Gamble reported third-quarter earnings and sales that exceeded analyst estimates.

Benzinga
zerohedge.com
2 sources·Apr 24, 4:51 PM(11 days ago)·1m read
|
U.S. Stocks Trade Mixed as Dow Declines Over 150 Pointsvaluewalk.com
Audio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.

U.S. stocks traded mixed midway through the session on Friday, according to market data. In contrast, the NASDAQ Composite rose 1.45% to 24,793.34, and the S&P 500 gained 0.65% to 7,154.55.

technology shares led the market, increasing by 1.6% on Friday. Health care stocks lagged, declining by 1.3% during the same trading session.

Gamble reported third-quarter earnings of $1.59 per share, surpassing the analyst consensus estimate of $1.56 per share. The company also posted quarterly sales of $21.235 billion, which exceeded the consensus estimate of $20.516 billion. Intel shares rose 23% to $81.92 following the company's report of first-quarter financial results that beat expectations.

Key Facts

Dow Jones decline
fell 0.35% to 49,137.50
NASDAQ gain
rose 1.45% to 24,793.34
S&P 500 increase
gained 0.65% to 7,154.55
Procter & Gamble earnings
$1.59 per share, beating $1.56 estimate
Intel stock rise
up 23% to $81.92 on earnings beat

Story Timeline

4 events
  1. Friday midday trading

    U.S. stocks traded mixed, with the Dow down 0.35% to 49,137.50.

    1 sourceBenzinga
  2. Friday

    Information technology shares rose 1.6%, while health care stocks fell 1.3%.

    1 sourceBenzinga
  3. Recent reporting

    Procter & Gamble announced third-quarter earnings of $1.59 per share and sales of $21.235 billion, beating estimates.

    1 sourceBenzinga
  4. Recent reporting

    Intel shares increased 23% to $81.92 after better-than-expected first-quarter results.

    1 sourceBenzinga

Potential Impact

  1. 01

    Intel's stock surge could boost investor confidence in semiconductor firms.

  2. 02

    Technology sector gains may support broader market recovery in upcoming sessions.

  3. 03

    Health care sector declines could pressure related stocks in short-term trading.

  4. 04

    Procter & Gamble's earnings beat might influence consumer goods sector sentiment.

Transparency Panel

Sources cross-referenced2
Framing risk0/100 (low)
Confidence score65%
Synthesized bySubstrate AI
Word count114 words
PublishedApr 24, 2026, 4:51 PM
Bias signals removed3 across 2 outlets
Signal Breakdown
Loaded 2Amplifying 1

Related Stories

Oil Prices Fall More Than 12% on Reports of US-Iran Dealrte.ie
finance56 min agoFraming60Framing risk60/100Rewrite inherits consensus framing by leading with unconfirmed deal rumors as the driver of price action while burying the absence of confirmation and using Trump's warning as the rebound trigger.Click to jump to full framing analysis

Oil Prices Fall More Than 12% on Reports of US-Iran Deal

Reports indicate the United States and Iran are close to a 14-point memorandum of understanding to conclude the ongoing conflict. Oil prices fell sharply after the news emerged before partially recovering following an Iranian announcement. President Donald J. Trump stated that co…

Cnbc
KO
SE
3 sources
Restaurant Brands International Reports Q1 2026 EarningsDonald Trung Quoc Don (Chữ Hán: 徵國單) - Wikimedia Commons - © CC BY-SA 4.0 International.(Want to use this image?)Original publication 📤: --Donald Trung 『徵國單』 (No Fake News 💬) (WikiProject Numismatics 💴) (Articles 📚) 08:31, 13 September 2022 (UTC) / Wikimedia (CC BY-SA 4.0)
finance56 min agoDeveloping

Restaurant Brands International Reports Q1 2026 Earnings

Restaurant Brands International posted first-quarter adjusted earnings per share of 86 cents and revenue of $2.26 billion. Both figures exceeded Wall Street forecasts. Net income attributable to common shareholders reached $338 million.

Reuters
CNBC
2 sources
White House Projects $529 Billion in Potential Savings Over Decade From Trump-Era Drug Pricing PolicyA derivative work by MaesterTonberry from a variety of images credited above. / Wikimedia (CC BY-SA 4.0)
finance2 hrs agoDeveloping

White House Projects $529 Billion in Potential Savings Over Decade From Trump-Era Drug Pricing Policy

White House economists projected $529 billion in savings over the next decade from agreements President Donald Trump reached with pharmaceutical companies. The analysis also forecasts $64.3 billion in Medicaid savings and up to $733 billion if the framework expands.

Benzinga
1 source